GenoSensor System, showing results of hybridization to biochip (left) and display of data using software (right). Gene amplification and rearrangements have long been known to occur in cancer cells, and the connection between these events and disease outcome is of great interest, especially in light of the relationship between HER-2/neu amplification and a poor breast cancer prognosis. It is with this backdrop that Vysis, a genomic disease management company based in Downer's Grove, Ill., has
 GenoSensor System, showing results of hybridization to biochip (left) and display of data using software (right). |
The PathVysion HER-2/neu DNA probe is not the first of its kind to be offered. However, this kit is unique in that it includes the means to normalize the signal ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
